StockData
Neurocrine Biosciences Inc logo

Neurocrine Biosciences Inc (NBIX) stock

NBIXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/306% below fair value
$165.92+0.61 (+0.37%)

Close on Nov 17, 2026Market cap $16.87BP/E 24.3Yield –

Neurocrine Biosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Neurocrine Biosciences's EV/EBITDA was 21.8× on Nov 11, 2026, against 25.5× a year earlier. Over the last 5 years it ranged from 16.9× to 156.9×, with a median of 28.1×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202621.8×−1.9
2025Dec 31, 202523.7×+1.9
2024Dec 31, 202421.7×−36.3
2023Dec 29, 202358.1×−39.6
2022Dec 30, 202297.7×+63.0
2021Dec 31, 202134.7×−22.5
2020Dec 31, 202057.2×−120.5
2019Dec 31, 2019177.7×−29.3
2018Dec 31, 2018207.0×−75.1
2013Apr 30, 2013282.1×+271.2
2012Oct 31, 201210.9×+0.4
2011Dec 30, 201110.5×–

More Neurocrine Biosciences figures

See a number that looks wrong?